Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
| Author | |
|---|---|
| Abstract |
:
Few studies have assessed the safety and efficacy of potential asthma medications in children younger than 5 years. We descriptively assessed the safety and efficacy of tiotropium, a long-acting anticholinergic drug, in children aged 1-5 years with persistent asthmatic symptoms. |
| Year of Publication |
:
2018
|
| Journal |
:
The Lancet. Respiratory medicine
|
| Date Published |
:
2018
|
| ISSN Number |
:
2213-2600
|
| URL |
:
http://linkinghub.elsevier.com/retrieve/pii/S2213-2600(18)30012-2
|
| DOI |
:
10.1016/S2213-2600(18)30012-2
|
| Short Title |
:
Lancet Respir Med
|
| Download citation |
